Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

List includes medications for diabetes, cancer, arthritis, and more ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...